Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Nonemergency Acute Care: When It's Not the Medical Home.

Conners GP, Kressly SJ, Perrin JM, Richerson JE, Sankrithi UM; COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE; COMMITTEE ON PEDIATRIC EMERGENCY MEDICINE; SECTION ON TELEHEALTH CARE; SECTION ON EMERGENCY MEDICINE; SUBCOMMITTEE ON URGENT CARE; TASK FORCE ON PEDIATRIC PRACTICE CHANGE.

Pediatrics. 2017 May;139(5). pii: e20170629. doi: 10.1542/peds.2017-0629.

PMID:
28557775
2.

Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.

Hwang JP, Suarez-Almazor ME, Cantor SB, Barbo A, Lin HY, Ahmed S, Chavez-MacGregor M, Donato-Santana C, Eng C, Ferrajoli A, Fisch MJ, McLaughlin P, Simon GR, Rondon G, Shpall EJ, Lok AS.

Cancer. 2017 May 18. doi: 10.1002/cncr.30729. [Epub ahead of print]

PMID:
28518219
3.

2017 Recommendations for Preventive Pediatric Health Care.

COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE; BRIGHT FUTURES PERIODICITY SCHEDULE WORKGROUP.

Pediatrics. 2017 Apr;139(4). pii: e20170254. doi: 10.1542/peds.2017-0254. Epub 2017 Feb 17.

PMID:
28213605
4.

ALK: a tyrosine kinase target for cancer therapy.

Holla VR, Elamin YY, Bailey AM, Johnson AM, Litzenburger BC, Khotskaya YB, Sanchez NS, Zeng J, Shufean MA, Shaw KR, Mendelsohn J, Mills GB, Meric-Bernstam F, Simon GR.

Cold Spring Harb Mol Case Stud. 2017 Jan;3(1):a001115. doi: 10.1101/mcs.a001115. Review.

5.

A New Era in Quality Measurement: The Development and Application of Quality Measures.

Adirim T, Meade K, Mistry K; COUNCIL ON QUALITY IMPROVEMENT AND PATIENT SAFETY; COMMITTEE ON PRACTICE AND AMBULATORY MANAGEMENT.

Pediatrics. 2017 Jan;139(1). pii: e20163442. doi: 10.1542/peds.2016-3442.

PMID:
28025242
6.

Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung Cancer.

Shen C, Kehl KL, Zhao B, Simon GR, Zhou S, Giordano SH.

Clin Lung Cancer. 2017 Jul;18(4):e233-e241. doi: 10.1016/j.cllc.2016.11.002. Epub 2016 Nov 11.

PMID:
28024927
7.

Recent Advances in Immunotherapy in Metastatic NSCLC.

Bansal P, Osman D, Gan GN, Simon GR, Boumber Y.

Front Oncol. 2016 Nov 14;6:239. eCollection 2016. Review.

8.

Countering Vaccine Hesitancy.

Edwards KM, Hackell JM; COMMITTEE ON INFECTIOUS DISEASES, THE COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE.

Pediatrics. 2016 Sep;138(3). pii: e20162146. doi: 10.1542/peds.2016-2146. Review.

PMID:
27573088
9.

Medical Versus Nonmedical Immunization Exemptions for Child Care and School Attendance.

COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE; COMMITTEE ON INFECTIOUS DISEASES; COMMITTEE ON STATE GOVERNMENT AFFAIRS; COUNCIL ON SCHOOL HEALTH; SECTION ON ADMINISTRATION AND PRACTICE MANAGEMENT.

Pediatrics. 2016 Sep;138(3). pii: e20162145. doi: 10.1542/peds.2016-2145.

PMID:
27573087
10.

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC.

Bansal P, Osman D, Gan GN, Simon GR, Boumber Y.

Front Oncol. 2016 May 4;6:112. doi: 10.3389/fonc.2016.00112. eCollection 2016. Review.

11.

Recommended Childhood and Adolescent Immunization Schedule--United States, 2016.

COMMITTEE ON INFECTIOUS DISEASES; American Academy of Pediatrics.

Pediatrics. 2016 Mar;137(3):e20154531. doi: 10.1542/peds.2015-4531. Epub 2016 Feb 1. No abstract available.

12.

Procedures for the Evaluation of the Visual System by Pediatricians.

Donahue SP, Baker CN; Committee on Practice and Ambulatory Medicine, American Academy of Pediatrics; Section on Ophthalmology, American Academy of Pediatrics; American Association of Certified Orthoptists; American Association for Pediatric Ophthalmology and Strabismus; American Academy of Ophthalmology.

Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-3597. Epub 2015 Dec 7.

13.

Nontherapeutic Use of Antimicrobial Agents in Animal Agriculture: Implications for Pediatrics.

Paulson JA, Zaoutis TE; Council on Environmental Health; Committee on Infectious Diseases.

Pediatrics. 2015 Dec;136(6):e1670-7. doi: 10.1542/peds.2015-3630. Epub 2015 Nov 16. Review.

14.

A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin.

Gray JE, Infante JR, Brail LH, Simon GR, Cooksey JF, Jones SF, Farrington DL, Yeo A, Jackson KA, Chow KH, Zamek-Gliszczynski MJ, Burris HA 3rd.

Invest New Drugs. 2015 Dec;33(6):1187-96. doi: 10.1007/s10637-015-0278-7. Epub 2015 Sep 25.

PMID:
26403509
15.

Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung.

Somaiah N, Fidler MJ, Garrett-Mayer E, Wahlquist A, Shirai K, Buckingham L, Hensing T, Bonomi P, Simon GR.

Oncoscience. 2014 Aug 7;1(8):522-8. eCollection 2014.

16.

Lung adenocarcinoma with concurrent KRAS mutation and ALK rearrangement responding to crizotinib: case report.

Campos-Gomez S, Lara-Guerra H, Routbort MJ, Lu X, Simon GR.

Int J Biol Markers. 2015 May 26;30(2):e254-7. doi: 10.5301/jbm.5000127.

17.

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.

Morgensztern D, Campo MJ, Dahlberg SE, Doebele RC, Garon E, Gerber DE, Goldberg SB, Hammerman PS, Heist RS, Hensing T, Horn L, Ramalingam SS, Rudin CM, Salgia R, Sequist LV, Shaw AT, Simon GR, Somaiah N, Spigel DR, Wrangle J, Johnson D, Herbst RS, Bunn P, Govindan R.

J Thorac Oncol. 2015 Jan;10(1 Suppl 1):S1-63. doi: 10.1097/JTO.0000000000000405.

18.

Physician health and wellness.

McClafferty H, Brown OW; Section on Integrative Medicine; Committee on Practice And Ambulatory Medicine; Section on Integrative Medicine.

Pediatrics. 2014 Oct;134(4):830-5. doi: 10.1542/peds.2014-2278.

19.

nab-Paclitaxel for the treatment of advanced squamous non-small-cell lung cancer: a comprehensive update.

Simon GR.

Clin Lung Cancer. 2014 Nov;15(6):391-7. doi: 10.1016/j.cllc.2014.07.003. Epub 2014 Aug 15. Review.

PMID:
25246384
20.

Molecular pathways and therapeutic targets in lung cancer.

Shtivelman E, Hensing T, Simon GR, Dennis PA, Otterson GA, Bueno R, Salgia R.

Oncotarget. 2014 Mar 30;5(6):1392-433. Review.

Supplemental Content

Loading ...
Support Center